Scientific Industries announced that it has sold its Genie Division to Troemner, LLC, a manufacturing sister company of OHAUS Corporation, for $9.6 million in cash, less working capital adjustments, plus up to $1.5 million in cash earnout over twelve months. The Company also entered into a transition services agreement and supply agreement under which it has agreed to supply product to the Buyer and provide transition services of the acquired business for up to a year.
“For more than 70 years, Scientific Industries was known as the world leader in vortexing technologies and as the pioneer and inventor of the vortex mixer,” said Helena Santos, CEO of Scientific Industries. “Today, we are transforming into a deep-tech, AI-enabling company focused on two of the pharmacy and pharmaceutical industries’ largest opportunities: pharmacy automation and biomanufacturing. With SaaS-enabled, data-driven IP models and integrated hardware/software platforms, we are building long-term value for our shareholders and measurable impact for our customers.”
Scientific Industries’ Torbal division has rapidly evolved from analogue pharmacy scales to become a leader in cloud-based pharmacy automation. The company launched its first VIVID automated pill counter in 2020 in response to the nationwide shortage of pharmacists, often referred to as “Pharmageddon.” Since then, the platform has expanded to three devices, including the VIVID Workstation — a premier cloud-connected automated pill counting solution.
To date, nearly 2,000 VIVID units have been deployed, supporting the monthly dispensing of millions of prescriptions. Scientific Industries is now developing the pharmacy industry’s first machine learning (“ML”) pill library, expected to launch in Q1 2026. This will allow the platform to continuously improve in accuracy and efficiency, create a robust data library and unlock new opportunities across the pharmacy value chain — from manufacturers and dispensers to law enforcement.
“Our vision is to become the ‘digital leader of retail pharmacy’ by providing critical infrastructure and intelligence to an underserved market of 24,000+ independent pharmacies in North America,” added Santos.
